Lymphoma Trial, Recruiting NCT06112639 Sponsor: Fondazione Don Carlo Gnocchi ETS Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06112639
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 85 years old
  • People who have completed at least 5 years of education
  • People who are willing to participate and sign a consent form
  • People who have a confirmed diagnosis of Multiple Sclerosis (MS) meeting specific disease criteria — including a disability score of 4.5 or below on a standard MS scale, a relapsing-remitting pattern of the disease, and no relapses or steroid treatment for at least one month — OR people who have a diagnosis of early memory or thinking difficulties (pre-MCI or MCI) that may be related to Alzheimer's Disease, with mild or no functional impact on daily life (confirm with trial site)
  • People who score above a set threshold on a standard screening test for cognitive (thinking and memory) difficulties

Who may not be able to join:

  • People who have other health conditions that would make it unsafe to take part in a home-based program, such as balance problems, a fall in the past 6 months, or the need for a walking aid
  • People with significant hearing or vision problems
  • People in the memory/thinking difficulties group who do not have a family member, carer, or trusted person available to support them during the trial
  • People who are not currently living in their own home
  • People in the MS group who have a score greater than 3 on the part of their MS assessment that measures how well the cerebellum (the part of the brain that controls coordination and balance) is functioning

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Pia Amato, IRCCS Fondazione Don Carlo Gnocchi ONLUS

Phone: +390240308952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione Don Carlo Gnocchi ETS
Registry
ClinicalTrials.gov
Start date
31 January 2024
Est. completion
1 May 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Adherence to treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov